Luke Riggan

Research Project:

Investigating the role of IFNγ inducible genes in tumor immunogenicity.

Publications:

CRISPR Cas9 Ribonucleoprotein-mediated Genomic Editing in Mature Primary Innate Immune CellsRiggan, L., Hildreth, A.D., Rolot, M., Wong, Y.Y., Satyadi, W., Sun R., Huerta C., O’Sullivan, T.E. Cell Reports. (2020)

Protective role of type 1 innate lymphoid cells in acute liver injury – Nabekura, T., Riggan, L., Hildreth, A.D., O’Sullivan, T.E., Shibuya, A. Immunity (2020)

True Detective: Unraveling Group 1Innate Lymphocyte Heterogeneity – Riggan, L., Freud, A.G., & O’Sullivan, T.E.Trends in Immunology (2019)

Mouse cytomegalovirus-experienced ILC1S acquire a memory response dependent on the viral glycoprotein m12 – Weizman OE, Song E, Adams NM, Hildreth AD, Riggan L, Krishna C, Aguilar OA, Leslie CS Carlyle JR, Sun JC & O’Sullivan TE. Mouse cytomegalovirus-experienced ILC1S acquire a memory response dependent on the viral glycoprotein m12. Nature Immunology. 2019. doi: 10.1038/s41590-019-0430-1